A trial study of leukocyte labeling with stabilized Tc-99m D,L-HMPAO by methylene blue and sodium phosphate buffer

Citation
Ch. Kao et al., A trial study of leukocyte labeling with stabilized Tc-99m D,L-HMPAO by methylene blue and sodium phosphate buffer, APPL RAD IS, 50(3), 1999, pp. 513-519
Citations number
17
Categorie Soggetti
Multidisciplinary
Journal title
APPLIED RADIATION AND ISOTOPES
ISSN journal
09698043 → ACNP
Volume
50
Issue
3
Year of publication
1999
Pages
513 - 519
Database
ISI
SICI code
0969-8043(199903)50:3<513:ATSOLL>2.0.ZU;2-R
Abstract
We attempted to label leukocytes with stabilized Tc-99m D,L-HMPAO by methyl ene blue and sodium phosphate buffer (S-HMPAO). Methods: The results were c ompared with unstablized Tc-99m D,L-HMPAO (U-HMPAO). U-HMPAO was obtained b y reconstituting a commercial vial of D,L-HMPAO. Stabilization of the kit w as performed by the addition of methylene blue. The leukocytes were labeled using a modified published method. The test samples of S-HMPAO and U-HMPAO were prepared immediately, and stood for 0.5, 1, 2, 4, and 6 h, respective ly, at room temperature before analysis. Results: In comparison with U-HMPA O: (1) the radiochemical purity of S-HMPAO was higher; (2) the labeling eff iciencies of S-HMPAO labeled leukocytes were higher and consistent; (3) the viability of S-HMPAO labeled leukocytes was as high as the viability of U- HMPAO labeled leukocytes at any time; and (4) the percentages of disintegra ted from S-HMPAO labeled leukocytes in plasma were lower. Conclusion: S-HMP AO is more stable than U-HMPAO and can provide higher leukocyte labeling ef ficiency. S-HMPAO, therefore, has the potential to replace U-HMPAO as a leu kocyte-labeling agent. (C) 1999 Elsevier Science Ltd. All rights reserved.